2022 World Conference on Lung Cancer (ePosters)-EP08.02-157. Acquired EGFR Exon 19 Deletion Is a Resistance Mechanism to BRAF/MRK Inhibition in BRAF V600Emutant NSCLC

EP08.02-157. Acquired EGFR Exon 19 Deletion Is a Resistance Mechanism to BRAF/MRK Inhibition in BRAF V600Emutant NSCLC

Pdf Summary

Summary Not Available

Asset Subtitle

Fang Wu

Meta Tag

Speaker Fang Wu

Topic Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments